The use of phosphodiesterase inhibitors for the treatment of alopecia

References

• Keren A, Shemer A, Ullmann Y, et al. The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo. J Dermatol Sci. 2015;77:74–76.
   PubMed Web of Science ®Google Scholar
• Suarez-Farinas M, Ungar B, Noda S, et al. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing. J Allergy Clin Immunol. 2015;136:1277–1287.
   PubMed Web of Science ®Google Scholar
• Renert-Yuval Y, Guttman-Yassky E. A novel therapeutic paradigm for patients with extensive alopecia areata. Expert Opin Biol Ther. 2016;16:1005–1014. (2016).
   PubMed Web of Science ®Google Scholar
• Fischer TW, Hipler UC, Elsner P. Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro. Int J Dermatol. 2007;46:27–35. (2007).
   PubMed Web of Science ®Google Scholar
• Fischer TW, Herczeg-Lisztes E, Funk W, et al. Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor-beta2/insulin-like growth factor-1-mediated regulation of the hair cycle in male and female human hair follicles in vitro. Br J Dermatol. 2014;171:1031–1043.
   PubMed Web of Science ®Google Scholar
• Peeter & Seebar. Alpecin caffeine liquid promotes active hair roots, <https://www.alpecin.com/en-de/research/studies/alpecin-caffeine-liquid-promotes-active-hair-roots/> (2018).
   Google Scholar
• Famenini S, Goh C. Evidence for supplemental treatments in androgenetic alopecia. J Drugs Dermatol. 2014;13:809–812.
   PubMed Web of Science ®Google Scholar
• Bussoletti C, Mastropietro F, Talaini M, et al. Use of a caffeine shampoo for the treatment of male androgenetic alopecia. J Appl Cosmetol. 2010;28:153–162.
   Google Scholar
• Sisto T, Bussoletti C, Celleno L. Efficacy of a cosmetic caffeine shampoo in androgenetic alopecia management. II Note. J Appl Cosmetol. 2013;31:57–66.
   Google Scholar
• Sisto T, Bussoletti C, Celleno L. Cosmetic treatment of telogen effluvium with a caffeine shampoo. J Appl Cosmetol. 2013;31:139–145.
   Google Scholar
• Bussoletti C, Mastropietro F, Talaini M, et al. Use of a cosmetic caffeine lotion in the treatment of male androgenetic alopecia. J Appl Cosmetol. 2011;29:167–180.
   Google Scholar
• Pazoki-Toroudi H. The efficacy and safety of minoxidil 5% combination with azelaic acid 1.5% and caffeine 1% solution on male pattern hair loss. J Investig Dermatol. 2013;133:S84.
   Web of Science ®Google Scholar
• Golpour M, Rabbani H, Farzin D, et al. Comparing the effectiveness of local solution of minoxidil and caffeine 2.5% with local solution of minoxidil 2.5% in treatment of androgenetic alopecia. J Mazandaran Univ Med Sci. 2013;23:30–36.
   Google Scholar
• Dhurat R, Chitallia J, Jayaraaman AM, et al. An open-label randomized multicenter study assessing the noninferiority of a caffeine-based topical liquid 0.2% versus minoxidil 5% solution in male androgenetic alopecia. Skin Pharmacol Physiol. 2017;30:298–305.
   PubMed Web of Science ®Google Scholar
• Bussoletti C, Tolaini MV, Celleno L. Efficacy of a cosmetic phyto-caffeine shampoo in female androgenetic alopecia. G Ital Dermatol Venereol. 2018. DOI:10.23736/S0392-0488.18.05499-8
   PubMedGoogle Scholar
• Tanaka Y, Aso T, Ono J, et al. Androgenetic alopecia treatment in asian men. J Clin Aesthet Dermatol. 2018;11:32–35.
   PubMedGoogle Scholar
• Sarifakioglu E, Degim IT, Gorpelioglu C. Determination of the sildenafil effect on alopecia areata in childhood: an open-pilot comparison study. J Dermatolog Treat. 2006;17:235–237.
   PubMed Web of Science ®Google Scholar
• Liu LY, King BA. Lack of efficacy of apremilast in 9 patients with severe alopecia areata. J Am Acad Dermatol. 2017;77:773–774. (2017).
   PubMed Web of Science ®Google Scholar
• Medicine USNLO. Pilot study of the safety and efficacy of apremilast in subjects with moderate to severe alopecia areata, <https://clinicaltrials.gov/ct2/show/NCT02684123> (2018).
   Google Scholar
• Mikhaylov D, Pavel A, Yao C, et al. A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata. Arch Dermatol Res. 2019;311:29–36.
   PubMed Web of Science ®Google Scholar
• Shrager D. American Academy of Dermatology, Summer Academy Meeting, Boston, MA, 2016.
   Google Scholar
• Lopez S, d, Castro C, Calzada P, et al. Alopecia areata and severe psoriasis successfully treated with apremilast. Arch Clin Dermatol. 2017;1:2.
   Google Scholar
• Magdaleno-Tapial J, Valenzuela-Onate C, Sanchez-Carazo JL, et al. Improvement of alopecia areata with apremilast. Australas J Dermatol. 2018. DOI:10.1111/ajd.12934
   PubMed Web of Science ®Google Scholar
• Otberg N, Patzelt A, Rasulev U, et al. The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol. 2008;65:488–492.
   PubMed Web of Science ®Google Scholar
• Otberg N, Teichmann A, Rasuljev U, et al. Follicular penetration of topically applied caffeine via a shampoo formulation. Skin Pharmacol Physiol. 2007;20:195–198.
   PubMed Web of Science ®Google Scholar
• Trauer S, Patzelt A, Otberg N, et al. Permeation of topically applied caffeine through human skin–a comparison of in vivo and in vitro data. Br J Clin Pharmacol. 2009;68:181–186. (2009).
   PubMed Web of Science ®Google Scholar
• Zhai X, Lademann J, Keck CM, et al. Dermal nanocrystals from medium soluble actives – physical stability and stability affecting parameters. Eur J Pharm Biopharm. 2014;88:85–91.
   PubMed Web of Science ®Google Scholar
• Zhai X, Lademann J, Keck CM, et al. Nanocrystals of medium soluble actives–novel concept for improved dermal delivery and production strategy. Int J Pharm. 2014;470:141–150.
   PubMed Web of Science ®Google Scholar
• Brandner JM, Behne MJ, Huesing B, et al. Caffeine improves barrier function in male skin. Int J Cosmet Sci. 2006;28:343–347. (2006).
   PubMedGoogle Scholar
• Guttman-Yassky E, Ungar B, Noda S, et al. Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism. J Allergy Clin Immunol. 2016;137:301–304.
   PubMed Web of Science ®Google Scholar
• Choi HI, Kang BM, Jang J, et al. Novel effect of sildenafil on hair growth. Biochem Biophys Res Commun. 2018;505:685–691. (2018).
   PubMed Web of Science ®Google Scholar
• Medicine USNLO. Trial evaluating the efficacy of apremilast for the treatment of frontal fibrosing alopecia, <https://clinicaltrials.gov/ct2/show/NCT03422640?term=apremilast&cond=alopecia&rank=1> (2018).
   Google Scholar
• Medicine USNLO. Apremilast in the treatment of central centrifugal cicatricial alopecia (CCCA), <https://clinicaltrials.gov/ct2/show/NCT03521687?term=apremilast&cond=alopecia&rank=3> (2019).
   Google Scholar
• Choi HI, Kim DY, Choi SJ, et al. The effect of cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, on human hair growth with the dual promoting mechanisms. J Dermatol Sci. 2018;91:60–68.
   PubMed Web of Science ®Google Scholar
• Kim D, Choi H, Shin S, et al. The effect of cilostazol on hair growth: a novel therapeutic option for the treatment of hair loss. J Investig Dermatol. 2017;137:S150.
   Web of Science ®Google Scholar